Shaperon Inc. (KOSDAQ: 378800)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,920.00
-120.00 (-3.95%)
Dec 20, 2024, 9:00 AM KST
-17.51%
Market Cap 88.02B
Revenue (ttm) 91.24M
Net Income (ttm) -15.90B
Shares Out 30.14M
EPS (ttm) -632.39
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 852,358
Open 3,075.00
Previous Close 3,040.00
Day's Range 2,850.00 - 3,075.00
52-Week Range 1,389.00 - 5,900.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Mar 21, 2025

About Shaperon

Shaperon Inc., a clinical stage biotech company, develops novel inflammasome inhibitors targeting immune-mediated inflammatory disorders with high unmet medical needs and nanobody therapeutics. It offers NuGel, a gel type atopic dermatitis drug candidate in Phase 2 clinical trials; and NuSepin, an IV injection form of HY209 in Phase 2 clinical trials for use in the treatment of systemic inflammatory response syndrome. The company also provides Oral HY209, an oral formulation of HY209 for use in the treatment of neuroinflammatory diseases; and H... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2008
Employees 50
Stock Exchange KOSDAQ
Ticker Symbol 378800
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.